Management of soft tissue sarcomas of the extremities

Expert Review of Anticancer Therapy

Volumn 4, Issue 2, 2004, Pages 237-246

  Clarkson, Paul ^a   Ferguson, Peter C ^b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Brachytherapy; Chemotherapy; Doxorubicin; Ifosfamide; Radiotherapy; Sarcoma; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; GADOLINIUM; HEMOPOIETIC GROWTH FACTOR; IFOSFAMIDE; IMATINIB; MESNA; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE INHIBITOR; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; BRACHYTHERAPY; CANCER CENTER; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG TARGETING; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ENHANCEMENT; LIMB SALVAGE; LUNG METASTASIS; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PROGNOSIS; REVIEW; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; TUMOR BIOPSY;

EID: 1842739869     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737140.4.2.237     Document Type: Review

References (77)

1. National Cancer Institute. Cancer Facts. National Cancer Institute, MA, USA (2000).
2. Gerrand CH, Bell RS, Wunder JS et al. The influence of anatomic location on outcome in patients with soft tissue sarcoma of the extremity. Cancer 97, 485-492 (2003).
3. Davis AM, Devlin M, Griffin AM, Wunder JS, Bell RS. Functional outcome in amputation versus limb sparing of patients with lower extremity sarcoma: A matched case-control study. Arch. Phys. Med. Rehabil. 80, 615-618 (1999).
4. Karakousis CP, Zografos GC. Radiation therapy for high grade soft tissue sarcomas of the extremities treated with limb-preserving surgery. Eur. J. Surg. Oncol. 28, 431-436 (2002).
5. Karakousis CP, Driscoll DL. Treatment and local control of primary extremity soft tissue sarcomas. J. Surg. Oncol. 71, 155-161 (1999).
6. Popov P, Tukiainen E, Asko-Seljaavaara S et al. Soft tissue sarcomas of the lower extremity: Surgical treatment and outcome. Eur. J. Surg. Oncol. 26, 679-685 (2000).
7. Sadoski C, Suit H, Rosenberg AE, Mankin HJ, Efird J. Pre-operative radiation, surgical margins and local control of extremity sarcomas of soft tissues. J. Surg. Oncol. 52, 223-230 (1993).
8. O'Sullivan B, Pisters PW. Staging and prognostic factor evaluation in soft tissue sarcoma. Surg. Oncol. Clin. N. Am. 12, 333-353 (2003).
9. Mankin HJ, Mankin CJ, Simon MA. The hazards of the biopsy, revisited. Members of the Musculoskeletal Tumor Society. J. Bone Joint Surg. Am. 78, 656-663 (1996).
10. Noria S, Davis A, Kandel R et al. Residual disease following unplanned excision of soft-tissue sarcoma of an extremity. J. Bone Joint Surg. Am. 78, 650-655 (1996).
11. Vernon CB, Eary JF, Rubin BP, Conrad EU III, Schuetze S. FDG PET imaging guided re-evaluation of histopathologic response in a patient with high-grade sarcoma. Skeletal Radiol. 32, 139-142 (2003).
12. Fong Y, Coit DG, Woodruff JM, Brennan MF. Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann. Surg. 217, 72-77 (1993).
13. Mazeron JJ, Suit HD. Lymph nodes as sites of metastases from sarcomas of soft tissue. Cancer 60, 1800-1808 (1987).
14. Zagars GK, Ballo MT, Pisters PW et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: An analysis of 225 patients. Cancer 97, 2530-2543 (2003).
15. Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J. Clin. Oncol. 14, 1679-1689 (1996).
16. Cakir S, Dincbas FO, Uzel O, Koca SS, Okkan S. Multivariate analysis of prognostic factors in 75 patients with soft tissue sarcoma. Radiother. Oncol. 37, 10-16 (1995).
17. Vraa S, Keller J, Nielsen OS et al. Prognostic factors in soft tissue sarcomas: The Aarhus experience. Eur. J. Cancer 34, 1876-1882 (1998).
18. Coindre JM, Terrier P, Bui NB et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J. Clin. Oncol. 14, 869-877 (1996).
19. Clark J, Rocques PJ, Crew AJ et al. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nature Genet. 7, 502-508 (1994).
20. Downing JR, Head DR, Parham DM et al. Detection of the (11;22)(q24;q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction. Am. J. Pathol. 143, 1294-1300 (1993).
21. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin. Orthop. 153, 106-120 (1980).
22. Bears O, Henson D, Hutter R, Dennedy B. AJCC Cancer Staging Manual, 4th edition. Lippincott, Williams & Wilkins, PA, USA (1992).
23. Fleming I, Cooper J, Henson D et al. AJCC Cancer Staging Manual, 5th edition. Lippincott, Williams & Wilkins, PA, USA (1997).
24. Wunder JS, Healey JH, Davis AM, Brennan MF. A comparison of staging systems for localized extremity soft tissue sarcoma. Cancer 88, 2721-2730 (2000).
25. Akerman M, Rydholm A, Persson BM. Aspiration cytology of soft-tissue tumors. The 10-year experience at an orthopedic oncology center. Acta Orthop. Scand. 56, 407-412 (1995).
26. Layfield LJ, Anders KH, Glasgow BJ, Mirra JM. Fine-needle aspiration of primary soft-tissue lesions. Arch. Pathol. Lab. Med. 110, 420-424 (1986).
27. Oland J, Rosen A, Reif R, Sayfan J, Orda R. Cytodiagnosis of soft tissue tumors. J. Surg. Oncol. 37, 168-170 (1988).
28. Bennert KW, Abdul-Karim FW. Fine needle aspiration cytology vs. needle core biopsy of soft tissue tumors. A comparison. Acta Cytol. 38, 381-384 (1994).
29. Kilpatrick SE, Cappellari JO, Bos GD, Gold SH, Ward WG. Is fine-needle aspiration biopsy a practical alternative to open biopsy for the primary diagnosis of sarcoma? Experience with 140 patients. Am. J. Clin. Pathol. 115, 59-68 (2001).
30. Kandel R, White L, Bell R et al. Histologic assessment of peritumoral oedema in soft tissue sarcoma. Proc. Connective Tissue Onc. Soc. (2003) (Abstract 120).
31. Simon MA, Enneking WF. The management of soft-tissue sarcomas of the extremities. J. Bone Joint Surg. Am. 58, 317-327 (1976).
32. Suit H, Spiro IJ. Soft tissue sarcomas: Radiation as a therapeutic option. Ann. Acad. Med. 25, 855-861 (1996).
33. Spiro IJ, Rosenberg AE, Springfield D, Suit H. Combined surgery and radiation therapy for limb preservation in soft tissue sarcoma of the extremity: The Massachusetts General Hospital experience. Cancer Invest. 13, 86-95 (1995).
34. Gerrand CH, Wunder JS, Kandel RA et al. Classification of positive margins after resection of soft-tissue sarcoma of the limb predicts the risk of local recurrence. J. Bone Joint Surg. Br. 83, 1149-1155 (2001).
35. Weitz J, Antonescu CR, Brennan MF. Localized extremity soft tissue sarcoma: Improved knowledge with unchanged survival over time. J. Clin. Oncol. 21, 2719-2725 (2003).
36. Fuchs B, Davis AM, Wunder JS et al. Sciatic nerve resection in the thigh: A functional evaluation. Clin. Orthop. 382, 34-41 (2001).
37. Brooks AD, Gold JS, Graham D et al. Resection of the sciatic, peroneal, or tibial nerves: Assessment of functional status. Ann. Surg. Oncol. 9, 41-47 (2002).
38. Bell RS, O'Sullivan B, Langer F et al. Complications and functional results after limb-salvage surgery and radiotherapy for difficult mesenchymal neoplasms: A prospective analysis. Can. J. Surg. 32, 69-73 (1989).
39. Bell RS, O'Sullivan B, Davis A et al. Functional outcome in patients treated with surgery and irradiation for soft tissue tumours. J. Surg. Oncol. 48, 224-231 (1991).
40. Tokarek R, Bernstein E, Sullivan F, Uitto J, Mitchell J. Effect of therapeutic radiation on wound healing. Clin. Dermatol. 12, 57-70 (1994).
41. Wilson AN, Davis A, Bell R et al. Local control of soft tissue sarcoma of the extremity: The experience of a multidisciplinary sarcoma group with definitive surgery and radiotherapy. Eur. J. Cancer 30A, 746-751 (1994).
42. Ngan SY. Radiotherapy in soft tissue sarcoma of the extremities. Acta Orthop. Scand. Suppl. 273, 112-116 (1997).
43. Nielsen OS, Cummings B, O'Sullivan B et al. Preoperative and postoperative irradiation of soft tissue sarcomas: Effect of radiation field size. Int. J. Radiat. Oncol. Biol. Phys. 21, 1595-1599 (1991).
44. Cheng EY, Dusenbery KE, Winters MR, Thompson RC. Soft tissue sarcomas: Preoperative versus postoperative radiotherapy. J. Surg. Oncol. 61, 90-99 (1996).
45. Karasek K, Constine LS, Rosier R. Sarcoma therapy: Functional outcome and relationship to treatment parameters. Int. J. Radiat. Oncol. Biol. Phys. 24, 651-656 (1992).
46. Holt G, Wunder J, Griffin A, Bell R. Fractures following radiation therapy and limb salvage surgery for soft tissue sarcomas: High versus low dose radiotherapy. Proc. Musculoskeletal Tumor Soc. (2002) (Abstract 41).
47. Peat BG, Bell RS, Davis A et al. Wound-healing complications after soft-tissue sarcoma surgery. Plast. Reconstr. Surg. 93, 980-987 (1994).
48. Bujko K, Suit HD, Springfield DS, Convery K. Wound healing after preoperative radiation for sarcoma of soft tissues. Surg. Gynecol. Obstet. 176, 124-134 (1993).
49. Saddegh MK, Bauer HC. Wound complication in surgery of soft tissue sarcoma. Analysis of 103 consecutive patients managed without adjuvant therapy. Clin. Orthop. 289, 247-253 (1993).
50. Skibber JM, Lotze MT, Seipp CA, Salcedo R, Rosenberg SA. Limb-sparing surgery for soft tissue sarcomas: Wound related morbidity in patients undergoing wide local excision. Surgery 102, 447-452 (1987).
51. Quill G, Gitelis S, Morton T, Piasecki P. Complications associated with limb salvage for extremity sarcomas and their management. Clin. Orthop. 260, 242-250 (1990).
52. O'Sullivan B, Davis AM, Turcotte R et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: A randomised trial. Lancet 359, 2235-2241 (2002).
53. O'Sullivan B, Davis A. A Randomized Phase III trial of pre-operative compared to post-operative radiotherapy in extremity soft tissue sarcoma. Proceedings of the 43rd Annual Meeting of the American Society of Therapeutic Radiology and Oncology. Int. J. Radiat. Oncol. Biol. Phys. 51 (Suppl. 1), 151-152 (2001).
54. Rosenblatt E, Meushar N, Bar-Deroma R et al. Interstitial brachytherapy in soft tissue sarcomas: The Rambam experience. Isr. Med. Assoc. J. 5, 547-551 (2003).
55. Pisters PW, Harrison LB, Leung DH et al. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J. Clin. Oncol. 14, 859-868 (1996).
56. Borden EC, Baker LH, Bell RS et al. Soft tissue sarcomas of adults: State of the translational science. Clin. Cancer Res. 9, 1941-1956 (2003).
57. Antman K, Suit H, Amato D et al. Preliminary results of a randomized trial of adjuvant doxorubicin for sarcomas: Lack of apparent difference between treatment groups. J. Clin. Oncol. 2, 601-608 (1984).
58. Lerner HJ, Amato DA, Savlov ED et al. Eastern Co-operative Oncology Group: A comparison of adjuvant doxorubicin and observation for patients with localized soft tissue sarcoma. J. Clin. Oncol. 5, 613-617 (1987).
59. Alvegard TA, Sigurdsson H, Mouridsen H et al. Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: A randomized trial of the Scandinavian Sarcoma Group. J. Clin. Oncol. 7, 1504-1513 (1989).
60. Gherlinzoni F, Bacci G, Picci P et al. A randomized trial for the treatment of high-grade soft-tissue sarcomas of the extremities: preliminary observations. J. Clin. Oncol. 4, 552-558 (1986).
61. Rosenberg SA, Tepper J, Glatstein E et al. Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities. Cancer 52, 424-434 (1983).
62. Chang AE, Kinsella T, Glatstein E et al. Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity. J. Clin. Oncol. 6, 1491-1500 (1988).
63. Bramwell V, Rouesse J, Steward W et al. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma reduced local recurrence but no improvement in survival: A study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J. Clin. Oncol. 12, 1137-1149 (1994).
64. Frustaci S, Gherlinzoni F, De Paoli A et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: Results of the Italian randomized co-operative trial. J. Clin. Oncol. 19, 1238-1247 (2001).
65. Sarcoma Meta-analysis Collaboration. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: Meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet 350, 1647-1654 (1997).
66. van Oosterom AT, Judson I, Verweij J et al. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: A Phase I study. Lancet 358, 1421-1423 (2001).
67. Heinrich M, Corless C, Blanke C et al. KIT mutational status predicts clinical response to STI571 in patients with metastatic gastrointestinal stromal tumors (GISTs). Prog. Proc. Am. Soc. Clin. Oncol. 21, 2a (2002).
68. Sirvent N, Maire G, Pedeutour F. Genetics of dermatofibrosarcoma protuberans family of tumors: From ring chromosomes to tyrosine kinase inhibitor treatment. Genes Chromosomes Cancer 37, 1-19 (2003).
69. Rubin BP, Schuetze SM, Eary JF et al. Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans. J. Clin. Oncol. 20, 3586-3591 (2002).
70. Zagars GK, Ballo MT, Pisters PW et al. Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 57, 739-747 (2003).
71. Spillane AJ, Fisher C, Thomas JM. Myxoid liposarcoma: The frequency and the natural history of nonpulmonary soft tissue metastases. Ann. Surg. Oncol. 6, 389-394 (1999).
72. Temple LK, Brennan MF. The role of pulmonary metastasectomy in soft tissue sarcoma. Semin. Thorac. Cardiovasc. Surg. 14, 35-44 (2002).
73. Bramwell V, Anderson D, Charette M. Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft-tissue sarcoma: A meta-analysis and clinical practice guideline. Sarcoma 4, 103-412 (2000).
74. Edmonson JH, Ryan LM, Blum RH et al. Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin and cisplatin against advanced soft tissue sarcomas. J. Clin. Oncol. 11, 1269-1275 (1993).
75. Santoro A, Tursz T, Mouridsen H et al. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: A randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J. Clin. Oncol. 13, 1537-1545 (1995).
76. Ferguson PC, Boynton EL, Wunder JS et al. Intradermal injection of autologous dermal fibroblasts improves wound healing in irradiated skin. J. Surg. Res. 85, 331-338 (1999).
77. Dantzer D, Ferguson P, Hill RP et al. Effect of radiation and cell implantation on wound healing in a rat model. J. Surg. Oncol. 83, 185-190 (2003).